TY - JOUR
T1 - Hypertriglyceridemia
T2 - management of atherogenic dyslipidemia.
AU - Bersot, Thomas
AU - Haffner, Steven
AU - Harris, William S.
AU - Kellick, Kenneth A.
AU - Morris, Charlene M.
PY - 2006/7
Y1 - 2006/7
N2 - Elevated triglycerides are now considered an independent risk factor for coronary heart disease and continue to be a major risk for acute pancreatitis, especially when levels exceed 1000 mg/dL (SOR: B). Elevated triglycerides are a component of atherogenic dyslipidemia and often signal the presence of other conditions (eg, metabolic syndrome, type 2 diabetes mellitus) associated with an increased cardiovascular risk (SOR: A). When evaluating a patient with elevated triglycerides, it is important to be cognizant of all atherogenic lipoproteins to more accurately determine the risk of coronary heart disease (SOR: C). Patients with hypertriglyceridemia should first achieve their low-density lipoprotein cholesterol goal, followed by their non-high-density lipoprotein cholesterol goal (SOR: C). Fibrates, niacin, and omega-3 acid ethyl esters are highly effective at reducing triglycerides, while statins are considered moderately efficacious (SOR: A).
AB - Elevated triglycerides are now considered an independent risk factor for coronary heart disease and continue to be a major risk for acute pancreatitis, especially when levels exceed 1000 mg/dL (SOR: B). Elevated triglycerides are a component of atherogenic dyslipidemia and often signal the presence of other conditions (eg, metabolic syndrome, type 2 diabetes mellitus) associated with an increased cardiovascular risk (SOR: A). When evaluating a patient with elevated triglycerides, it is important to be cognizant of all atherogenic lipoproteins to more accurately determine the risk of coronary heart disease (SOR: C). Patients with hypertriglyceridemia should first achieve their low-density lipoprotein cholesterol goal, followed by their non-high-density lipoprotein cholesterol goal (SOR: C). Fibrates, niacin, and omega-3 acid ethyl esters are highly effective at reducing triglycerides, while statins are considered moderately efficacious (SOR: A).
UR - http://www.scopus.com/inward/record.url?scp=33746614799&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33746614799&partnerID=8YFLogxK
M3 - Article
C2 - 16822443
AN - SCOPUS:33746614799
SN - 0094-3509
VL - 55
SP - S1-8
JO - The Journal of family practice
JF - The Journal of family practice
IS - 7
ER -